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Headache is a frequent symptom in children and adolescents. Migraine is one 
of the most common types of primary headache disorders in children that at 
times can be extremely disabling. Many clinical features of migraine in children 
differ from that starting in adulthood. This review discusses the epidemiology, 
clinical features, management, and prognosis of migraine headache in children 
and adolescents. 
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Introduction
Although historical references to children’s headaches date back to 1000 years (1), 
the modern era of the headache studies in children and adolescents began a few 
decades ago. Headaches are very common during childhood and become increasingly 
frequent during adolescence. Epidemiological studies state that 14-25% of children 
experience headache episodes (2,3). A headache disorder affects the healthy lifestyle 
of child and his family and results in significant disability including time lost from 
school. Among children who experienced migraine, 42% lost school time because 
of their headaches (4). 
The international Headache Society (IHS) (5) diagnostic criteria have been widely 
accepted for adults, but less so far for children. Many scientists have proposed 
revisions to the IHS criteria for children and adolescents with migraine (6). Based 
on the temporal pattern plotted against the severity, headache in children is divided 
to five patterns: acute, acute recurrent (migraine), chronic progressive (organic), 
chronic non-progressive (tension-type), and mixed (tension-type and migraine) (7). 
Acute recurrent headaches are usually migrainous (4). Migraine is a common episodic 
headache, which is characterized by attacks consisting of various combinations of 
headache and neurological, gastrointestinal, and autonomic symptoms. Migraine 
attacks are often precipitated by trigger phenomena. Provocative factors include diet, 
odors, medication, hunger, illness, anxiety, stress, excessive sleep or lack of sleep, 
fatigue, menses, and travel (8). Epidemiological studies have shown that 3-7% of 
the pediatric population suffers from migraine (9). At the age of 7 years, migraine 
prevalence ranges from 1.2 to 3.2%. Between 7 and 15 years of age, prevalence 
ranges from 4 to 11% (2,3,10). Migraine prevalence is higher in boys than girls at 
3 to 7 years of age. Prevalence is equal in boys and girls aged 7 to 11 years and is 
higher in girls after age 11 (2). The clinical study of Bille (11,12) on children with 
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migraine, followed up for more than 40 years, shows that 
50% of the patients continuously suffered from migraine 
attacks throughout their life. Sillanpaa (13) found 22% 
of remissions in 355 children with migraine followed 
up for 7 years if the starting age was before 8 years of 
age and 25% if starting age was after 14. The earlier the 
migraine attacks begin the more likely is an unfavorable 
clinical course (9). Children with migraine without aura 
are usually younger than those with aura (14).
Many clinical characteristics of pediatric migraine 
differ from that starting in adulthood. Children appear 
to have fewer attacks per month with shorter duration 
in their younger age. Their headache attacks seem less 
severe and more easily controlled. As children mature 
into adolescents, the numbers as well as the duration of 
attacks increase and the attacks become more difficult 
to treat.
A positive family history was recorded in 50 to 90% of 
migrainous children (9). This positive family history is 
more commonly recorded in children than in adults (15). 
However, disagreement exists regarding the mode of 
inheritance. Some of these families have mitochondrial 
diseases. Familial hemiplegic migraine has been related 
to mutations in a brain calcium channel in chromosomes 
1 and 19 (16).
Migraine with Aura
Migraine with aura is less prevalent in children and 
adolescents than migraine without aura. Approximately 
in 15% to 30% of migrainous children, aura was reported. 
When aura is present, it can be visual or somatic and may 
include moving lights, distorted images, colored lights, 
and fortification spectra. Somatic disturbances such 
as dysphasia, hemiplegia, and speech disturbances are 
less frequent. The aura usually lasts 15-30 minutes and 
may be followed by a bilateral headache or a unilateral 
cephalalgia contralateral to the aura. The headache is 
usually severe and throbbing. Migraine with aura is 
frequently associated with photophobia, phonophobia 
gastrointestinal symptoms such as nausea, vomiting, 
and anorexia, abdominal pain and pallor. This type of 
headache tends to be relieved by sleep (17). 
In some cases distortions of somatic perception may 
precede the migraine attacks, such as the ´´Alice in 
wonderland`` syndrome. ´´Alice in wonderland`` 
syndrome consists of bizarre visual illusions or 
hallucinations and spatial distortions that precede 
migraine headaches. Children may describe fluctuations 
in size and shape of the objects such as metamorphopsia, 
micropsia, macropsia, or teleopsia before the cephalalgia 
begins. However, it should be noted that this syndrome 
has also been reported in acute and persistent Epstein-
Barr virus infection (18), coxsackievirus infection (19), 
frontal lobe epilepsy (20), and drug ingestion such as 
triazolam (21).
Migraine without Aura
Migraine without aura is the most common type of 
migraine in children and adolescents. Although aura is 
absent in this type of headache, many children describe 
a prodrome prior to the pain attacks. Personality change, 
irritability, lethargy, and pallor may last from minutes 
to hours before appearance of headache. This type 
of headache is frequently associated with abdominal 
pain and gastrointestinal disturbances. The frequency, 
duration, and severity of attacks vary and usually occur 
twice a month. Pain is often resolved during an interval 
of sleep (22). Complicated migraine refers to migraine 
attacks associated with transient neurologic disturbances. 
Most patients recovered spontaneously without any 
sequelae. It is important to differentiate complicated 
migraine from serious intracranial diseases. Magnetic 
resonance imaging, magnetic resonance angiography, 
and electroencephalography have been suggested to 
rule out intracranial vascular disorders but not invasive 
angiography (23). Neuropsychological sequalae are not 
common and children with migraine headache are not in 
the risk for impaired cognitive development (24).
Basilar Migraine
Neurologic symptoms referable to disturbance in cortex, 
brain stem, and cerebellum function accompanied with 
occipital headache are common among but not restricted 
to adolescent women. Basilar migraine is known also 
to occur in children. Basilar migraine episodes begin 
with total blindness or visual field cuts accompanied 
or followed by admixtures of dizziness, vertigo ataxia, 
dysesthesia, dysarthria, tinnitus, and distal or perioral 
paresthesia. Loss of consciousness may also occur. 
Neurologic symptoms persist for approximately 30 
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minutes and are generally followed by a throbbing 
occipital headache (25). Electroencephalography between 
or during attacks may reveal occipital spike discharges, 
which should be differentiated from occipital epilepsy 
(26). Basilar migraine also should be differentiated from 
cerebral vascular diseases, demyelinating diseases, and 
occipital neuralgia.
Ophthalmoplegic Migraine 
Ophthalmoplegic migraine is the association of a 
complete or incomplete third nerve palsy and ipsilateral 
headache. Appearance of a dilated pupil in a lateral 
deviated eye may precede, co-exist with, or follow a 
severe and retroorbital headache. The ophtalmoplegia 
persists for a variable period of time after relieving of 
headache. Ophthalmoplegic migraine is very rare in 
children and adolescents (27). Aneurysms of cerebral 
arteries should be rule out.
Hemiplegic Migraine
Hemiplegic migraine is the association of recurrent 
hemiparesis and headache. Headache always appear 
contralateral to the hemiparesis. Some patients also 
described aphasia, meningismus, and visual field defect. 
Hemiparesis may precede, accompany, or follow the 
headache. Headache usually disappears before the 
hemiparesis. Cerebrospinal fluid pleocytosis has been 
observed in some patients. 
In some children, the attacks are familial. At least 
3 different genes have been implicated in familial 
hemiplegic migraine: the CACNA1A calcium subunit 
gene on chromosome 19p13 in half of the families with 
FHM, an unknown gene on chromosome 1 in a few 
families, and at least a third one, as a few families could 
not be linked to either chromosome 19 or chromosome 
1 (28). FHM is an autosomal dominant form of migraine 
with aura in which the aura is characterized by motor 
weakness of variable intensity. Symptoms include both 
typical migraine and severe episodes with prolonged 
aura, impaired consciousness ranging from confusion 
to profound coma, fever, and meningismus. Aura can 
persist for several days to weeks. Some patients also have 
fixed cerebellar symptoms and signs such as nystagmus 
and progressive ataxia. Cerebellar ataxia progresses 
independently of the frequency or severity of hemiplegic 
migraine attacks (29,30).
Migraine Variants
Based on IHS classification (5), migraine variants include 
two clinical entities, benign paroxysmal vertigo and 
alternating hemiplegia of children. Benign paroxysmal 
vertigo is common in children. It more commonly affects 
younger children, who develop sudden unsteadiness and 
grab everything for stability. Features that are common in 
migraine, i.e. pallor, nausea, phonophobia, photophobia, 
and nystagmus, commonly accompany benign 
paroxysmal vertigo. Migraine is twice as common in 
first-degree relatives compared to controls. This disorder 
evolves into migraine in later childhood and adolescence. 
Antihistamine therapy has been suggested (31,32).
The onset of alternating hemiplegia of children is 
usually before 18 months of age. Repeated episodes of 
hemiparesis, monoparesis, or quadriparesis are lasting 
from a few minutes to several days and accompanied by 
decreased tone and occasionally involuntary movements. 
Occurrence of tonic or dystonic attacks, nystagmus, 
dyspnea and other autonomic phenomena, development 
of cognitive impairment, and choreoathetotic movement 
disorder have been reported. Children are normal at 
the onset of attacks. Over time, more attacks occur and 
children demonstrate developmental deterioration. Sleep 
consistently relieves both weakness and associated 
paroxysmal phenomena. Treatment with the calcium 
channel blocker flunarizine may be helpful (33).
Pathophysiology
Current concepts regarding the pathogenesis of migraine 
are based on biochemical studies and techniques that 
measure cerebral blood flow, as well as biochemical 
determinants. The pathophysiology of migraine seems 
to be similar in children and adults. Several studies have 
been combined to produce the neurovascular hypothesis, 
which considers migraine an inherited sensitivity of the 
trigeminal vascular system. Spreading depression (SD), 
a self-propagating front of depolarization associated by 
a depression of the neuronal bioelectrical activity for a 
period of minutes, is proposed to play an important role 
in induction of aura phase (34). Furthermore, SD seems 
to be responsible for eliciting of pain and many other 
accompanied symptoms in migraine (34,35).
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Laboratory Tests
Nine percent of children with migraine have focal 
epileptiform discharges without any evidence of 
epilepsy or seizure. This incidence of 9% is higher 
than the incidence of benign focal epileptiform 
discharges in the normal population (36). Therefore, the 
electroencephalogram may help the clinicians to find 
such an occult epileptiform discharges. Most migraineurs 
without any symptoms of progressive neurologic disease 
and with normal neurologic examination do not require 
any imaging include computed tomography and magnetic 
resonance imaging. In children suffering from migraine 
and academic problems psycho-educational tests may be 
useful. 
Treatment
When a diagnosis of migraine has been made, a treatment 
plan should be formulated. Migraine treatment divides 
to pharmacologic and non-pharmacologic therapies. 
Pharmacologic treatments include symptomatic, abortive, 
and prophylactic treatments. There is no indication for 
drug prescription if migraine attacks are infrequent and 
easily relieved by sleep. For most patients, symptomatic 
or abortive therapy will suffice. For frequent appearance 
of migraine episodes, a combination of symptomatic, 
abortive, and prophylactic therapy will be needed. 
The most common type of pharmacologic treatment of 
childhood migraine is intermittent oral analgesic. Early 
administration of acetaminophen, ibuprofen, ketorolac, 
and naproxen sodium at appropriate doses is frequently 
effective. Combination of abovementioned drugs in some 
cases is helpful. Narcotics should be avoided during the 
initial stages. Narcotics and barbiturates are the second 
drugs of choice if the first agents fail. Once anorexia, 
vomiting and nausea occur, antiemetics may be helpful. 
When oral prescription is not possible, medicaments 
may be administered rectally or by injection.
Abortive substances can be administered orally, rectally, 
parentally, or intranasally. These agents include ergot 
preparations, non-steroidal anti-inflammatory drugs 
(NSAIDs), and triptans. Although ergot preparations 
are usually useful, due to the risk of nausea and rebound 
withdrawal headaches in children and adolescents, 
it should not use more than twice weekly. NSAIDs 
including flurbiprofen, naproxen, and meclofenamate are 
useful for the acute treatment of migraine. The maximal 
allowable dosage should be administered at the onset 
of episode. Sumatriptan nasal spray at doses of 10 and 
20 mg provided rapid relief in the adolescent migraine 
population (37,38).
Prophylactic treatment should be considered only 
when patient has frequent or prolonged attacks. Many 
substances are advised as preventive agents for migraine 
attacks in children and adolescents. These include calcium 
channel blockers such as verapamil and flunarazine, ß 
blockers such as propranolol, NSAIDs such as aspirin 
and flufenamic acid, tricyclic antidepressants such as 
amitriptyline, sodium valproate (39), and cyproheptadine. 
The ß blockers are first-line agents for migraine 
prevention. They also have anxiolytic effects. Calcium 
channel antagonist flunaraznie has been found to be 
effective and well-tolerated drug in childhood migraine 
prophylaxis (40). Sodium valporate, an anticonvulsant 
agent, suggested to be effective and safe in patients with 
childhood migraine (39). Non-sedating antidepressant 
drugs such as desipramine should be administered if 
patients initiate and maintain sleep easily.
Several non-pharmacologic treatments are suggested 
to reduce migraine attacks frequency. These include 
relaxation therapy, sleep hygiene, balanced diet, and 
appropriate exercise. If stress is a significant triggering 
agent, relaxation therapy and cognitive training considered 
beneficial (41,42). It is reported that mean duration and 
frequency of migraine attacks were significantly reduced 
by improving sleep hygiene (43). Avoiding foods that 
precipitate migraine episodes is useful. The education of 
patients and their parents may be effective.
Prognosis
Prognosis of migraine in children is favorable. Fifty 
percent of migraineurs improve within 6 months. Two-
thirds of children go into remission for 2 more years 
through adolescence and early adulthood. However, 
prognosis for migraineurs with adolescent onset is poor. 
Sixty percent of these patients report ongoing migraine 
after 30 years. Once a migraine onset is before 8 years 
of age, boys are more likely to remit than girls. The 
remission rate for patients whose onset is between 8 and 
14 years of age is 25%, and girls more likely to remit 
than boys (12,44).
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